Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Obatoclax, a Pan-BCL-2 Inhibitor, Downregulates Survivin to Induce Apoptosis in Human Colorectal Carcinoma Cells Via Suppressing WNT/β-catenin Signaling
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 5, Pages 1773
Publisher
MDPI AG
Online
2020-03-06
DOI
10.3390/ijms21051773
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators
- (2019) Thomas Steele et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Survivin at a glance
- (2019) Sally P. Wheatley et al. JOURNAL OF CELL SCIENCE
- Cancer treatment and survivorship statistics, 2019
- (2019) Kimberly D. Miller et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Blockade of STAT3 Signaling Contributes to Anticancer Effect of 5-Acetyloxy-6,7,8,4′-Tetra-Methoxyflavone, a Tangeretin Derivative, on Human Glioblastoma Multiforme Cells
- (2019) Yen-Po Cheng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer
- (2019) Qingyuan Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Novel Apoptosis-Inducing Agents for the Treatment of Cancer, a New Arsenal in the Toolbox
- (2019) Lim et al. Cancers
- Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
- (2019) Fengzhi Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Drugs and Clinical Approaches Targeting the Antiapoptotic Protein: A Review
- (2019) Zeping Han et al. Biomed Research International
- Colorectal cancer
- (2019) Evelien Dekker et al. LANCET
- Wnt signaling and drug resistance in cancer
- (2019) Zheng Zhong et al. MOLECULAR PHARMACOLOGY
- Signaling pathways involved in colorectal cancer progression
- (2019) Zahra Koveitypour et al. Cell and Bioscience
- Survivin antagonizes chemotherapy-induced cell death of colorectal cancer cells
- (2018) Anke Rauch et al. Oncotarget
- Therapeutic strategies involving survivin inhibition in cancer
- (2018) David Martínez‐García et al. MEDICINAL RESEARCH REVIEWS
- Obatoclax and Paclitaxel Synergistically Induce Apoptosis and Overcome Paclitaxel Resistance in Urothelial Cancer Cells
- (2018) Rocío Jiménez-Guerrero et al. Cancers
- Therapeutic potential of targeting the Wnt/β-catenin signaling pathway in colorectal cancer
- (2018) Xiaofei Cheng et al. BIOMEDICINE & PHARMACOTHERAPY
- Obatoclax and LY3009120 Efficiently Overcome Vemurafenib Resistance in Differentiated Thyroid Cancer
- (2017) Wei-Jun Wei et al. Theranostics
- The BH3 Mimetic Obatoclax Accumulates in Lysosomes and Causes Their Alkalinization
- (2016) Vasileios A. Stamelos et al. PLoS One
- Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells
- (2016) Zhongyuan Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies
- (2016) Xun Chen et al. Journal of Cancer
- Surgical Management of Liver Metastases From Colorectal Cancer
- (2016) Mashaal Dhir et al. Journal of Oncology Practice
- Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms
- (2015) Laura Novellasdemunt et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Pan-Bcl-2 inhibitor Obatoclax is a potent late stage autophagy inhibitor in colorectal cancer cells independent of canonical autophagy signaling
- (2015) Bruno Christian Koehler et al. BMC CANCER
- Pan-Bcl-2 Inhibitor Obatoclax Delays Cell Cycle Progression and Blocks Migration of Colorectal Cancer Cells
- (2014) Bruno Christian Koehler et al. PLoS One
- Obatoclax (GX15-070) triggers necroptosis by promoting the assembly of the necrosome on autophagosomal membranes
- (2013) F Basit et al. CELL DEATH AND DIFFERENTIATION
- GX15-070 (Obatoclax) Induces Apoptosis and Inhibits Cathepsin D- and L-Mediated Autophagosomal Lysis in Antiestrogen-Resistant Breast Cancer Cells
- (2013) J. L. Schwartz-Roberts et al. MOLECULAR CANCER THERAPEUTICS
- Obatoclax mesylate: pharmacology and potential for therapy of hematological neoplasms
- (2012) Jamal Joudeh et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosis
- (2011) Melisa A. Martínez-Paniagua et al. CELL CYCLE
- Expression of the Antiapoptotic Protein Survivin in Colon Cancer
- (2011) Jonathan M. Hernandez et al. Clinical Colorectal Cancer
- Mechanisms of Antileukemic Activity of the Novel Bcl-2 Homology Domain-3 Mimetic GX15-070 (Obatoclax)
- (2008) M. Konopleva et al. CANCER RESEARCH
- Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines
- (2008) Tsing-Fen Ho et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now